FEATURED REPORT:

The World Market for Point of Care, 10th Edition

All of the POC IVD market in one volume.  Glucose, COVID-19, flu, pregnancy and fertility, FOB, cardiac markers.

Point of care has made advances and this report provides markets for them.   Kalorama’s report is like many reports in one.
The next five years of Point of Care will answer the top questions about the IVD market
How can diagnostics promote wellness? How can diagnostics improve patient-provider encounters?  How can tests promote better selection and stewardship of drugs?  How can tests facilitate patient home or nursing home of the future? How can diagnostics ensure the next pandemic, if and when it arrives is appropriately handled?  The answers to these questions in many ways rely on the success of point-of-care solutions.

And because of this contribution, Point of Care diagnostics can earn a higher pricing and larger revenue growth than economized lab-based tests.  The tests covered in this report tend to grow at higher rates than overall IVD market.

Kalorama’s report provides hundreds of data points useful for business planning and forecasts scores of market segments.

Point of care is a highly competitive market.  There are many corporate profiles in this report.

Reserve your copy today.  

Instant Access to All of Kalorama’s IVD Market Research with a Subscription.

Kalorama Information is a publisher of highly-regarded in vitro diagnostics (IVD) market reports.  We can count among our customers the top clinical testing companies.  We also publish vaccine, life science tech, medical device reports.  Our reports provide expert, real-world market sizing and considered segmentation estimates.  Business planning tools you need to know where you stand and what opportunities lie ahead.

KNOWLEDGE CENTER: THE RIGHT WAY TO GO

Be ready with a Kalorama Knowledge Center Subscription, granting All Access to our elite market IVD market research reports, to every employee in your organization.  With searchability, downloadable Excel sheets, figures and tables for presentations.

With a subscription to Kalorama Information Knowledge Center, everyone in your company can have access to information when they need it  Scores of other companies have already signed up with Kalorama.  Your organization too can have unlimited access to the reports that have been published and will be published. Setup is easy, pricing is reasonable and includes global licensing and unlimited usage.  Contact our team today to get set up.

FOR MORE INFORMATION:
https://kaloramainformation.com/market-research-subscriptions/

SUBSCRIPTION: THE WAY COMPETITIVE COMPANIES USE RESEARCH.  

Buying reports is time-consuming and slow-paced.  It doesn’t match the pace of business.  To succeed you need a library of knowledge, so that as questions come up, you can spend time making decisions, advising team members, avoiding issues, and sizing up the competition instead of looking through report websites for information.

SHARE WITH EMPLOYEES IN YOUR ORGANIZATION

Perhaps you are in an organization with multiple employees who need market data.  Marketing wants market share data.    Business planning wants market opportunity sizing, Sales wants to get a head start on a lead list.  Your R&D head needs crucial backup for a product launch decision.  The CEO wants to know if a potential M&A target is all that or all hype.

EMAIL US: [email protected]

PHONE: (US):  703-778-3080

CONTACT US w/ Your Specific Questions and Needs.  A Representative Will Contact You.

https://kaloramainformation.com/contact/

Kalorama Information KNOWLEDGE CENTER

A subscription to the Kalorama Information Knowledge Center gives you access to hundreds of reports featuring
authoritative market research on the medical and healthcare sector.

Log-in to the Knowledge Center Learn more about the Knowledge Center

Kalorama Information provides the key market data, trends and insights you need to drive your business strategy and growth. Explore our latest research.

Biotechnology

Diagnostics

Medical Devices

Pharmaceuticals